ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $90,802,000 | +103084.1% | 62,193 | 0.0% | 0.00% | – |
| Q4 2016 | $88,000 | -58.1% | 62,193 | -48.2% | 0.00% | – |
| Q3 2016 | $210,000 | +2.4% | 120,093 | 0.0% | 0.00% | – |
| Q2 2016 | $205,000 | -13.1% | 120,093 | 0.0% | 0.00% | – |
| Q1 2016 | $236,000 | +0.4% | 120,093 | -3.0% | 0.00% | – |
| Q4 2015 | $235,000 | -0.4% | 123,811 | 0.0% | 0.00% | – |
| Q3 2015 | $236,000 | -51.3% | 123,811 | +18.6% | 0.00% | – |
| Q2 2015 | $485,000 | +13.8% | 104,411 | +7.2% | 0.00% | – |
| Q1 2015 | $426,000 | +31.9% | 97,411 | +5.0% | 0.00% | – |
| Q4 2014 | $323,000 | -8.5% | 92,811 | +10.3% | 0.00% | – |
| Q3 2014 | $353,000 | -28.4% | 84,111 | 0.0% | 0.00% | – |
| Q2 2014 | $493,000 | -7.0% | 84,111 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $530,000 | +7.7% | 84,111 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $492,000 | +14.2% | 84,111 | +2.8% | 0.00% | 0.0% |
| Q3 2013 | $431,000 | -31.5% | 81,811 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $629,000 | – | 81,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |